Next Article in Journal
The Effect of Exoskeletal-Assisted Walking on Spinal Cord Injury Bowel Function: Results from a Randomized Trial and Comparison to Other Physical Interventions
Next Article in Special Issue
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
Previous Article in Journal
Comparison of Two Different Sedation Protocols during Transvaginal Oocyte Retrieval: Effects on Propofol Consumption and IVF Outcome: A Prospective Cohort Study
Previous Article in Special Issue
The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis

1
Department of Gastroenterology, Changhua Christian Hospital, Changhua 50006, Taiwan
2
Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
3
Department of Ultrasound, Changhua Christian Hospital, Changhua 50006, Taiwan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(5), 965; https://doi.org/10.3390/jcm10050965
Submission received: 24 January 2021 / Revised: 18 February 2021 / Accepted: 18 February 2021 / Published: 2 March 2021
(This article belongs to the Special Issue Challenges in Nonalcoholic Steatohepatitis)

Abstract

In recent years, ultrasound attenuation imaging (ATI) has emerged as a new method to detect liver steatosis. However, thus far, no studies have confirmed the clinical utility of this technology. Using a retrospective database analysis of 28 patients with chronic liver disease who underwent ultrasound liver biopsy and ATI, we compared the presence and degree of steatosis measured by ATI with the results obtained through liver biopsy. The area under the receiver operating characteristic curve (AUROC) of the ATI for differentiating between normal and hepatic steatosis was 0.97 (95% confidence interval: 0.83–1.00). The AUROC of the ATI was 0.99 (95% confidence interval: 0.86–1.00) in grade ≥2 liver steatosis and 0.97 (95% confidence interval: 0.82–1.00) in grade 3. ATI showed good consistency and accuracy for the steatosis grading of liver biopsy. Therefore, ATI represents a novel diagnostic measurement to support the diagnosis of liver steatosis in non-invasive clinical practice.
Keywords: attenuation imaging; ultrasound; liver steatosis attenuation imaging; ultrasound; liver steatosis

Share and Cite

MDPI and ACS Style

Hsu, P.-K.; Wu, L.-S.; Yen, H.-H.; Huang, H.P.; Chen, Y.-Y.; Su, P.-Y.; Su, W.-W. Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis. J. Clin. Med. 2021, 10, 965. https://doi.org/10.3390/jcm10050965

AMA Style

Hsu P-K, Wu L-S, Yen H-H, Huang HP, Chen Y-Y, Su P-Y, Su W-W. Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis. Journal of Clinical Medicine. 2021; 10(5):965. https://doi.org/10.3390/jcm10050965

Chicago/Turabian Style

Hsu, Po-Ke, Li-Sha Wu, Hsu-Heng Yen, Hsiu Ping Huang, Yang-Yuan Chen, Pei-Yuan Su, and Wei-Wen Su. 2021. "Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis" Journal of Clinical Medicine 10, no. 5: 965. https://doi.org/10.3390/jcm10050965

APA Style

Hsu, P.-K., Wu, L.-S., Yen, H.-H., Huang, H. P., Chen, Y.-Y., Su, P.-Y., & Su, W.-W. (2021). Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis. Journal of Clinical Medicine, 10(5), 965. https://doi.org/10.3390/jcm10050965

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop